1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Basaloid squamous cell cancers arising from the lung: Next generation sequencing reveals PTCH1 mutations in the hedgehog pathway
    Meeting Abstract

    Li, B. T.; Rekhtman, N.; Won, H.; Arcila, M. E.; Rudin, C. M.; Kris, M. G.; Berger, M.; Paik, P.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • BAP1 inactivation in mesothelioma is highly prevalent
    Meeting Abstract

    Zauderer, M.; Cercek, A.; Rimner, A.; Rusch, V.; Adusumilli, P. S.; Nash, G. M.; Moreira, A.; Hmeljak, J.; Ladanyi, M.; Krug, L. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Identification of a first in class TWIST1 inhibitor with activity in KRAS mutant NSCLC
    Meeting Abstract

    Mazzacurati, L.; Cades, J.; Chatley, S.; Yochum, Z.; Nugent, K.; Somasundarum, A.; Cho, Y. J.; Rudin, C. M.; Tran, P.; Burns, T. F.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • RPS25 is essential for the translation of the Seneca Valley Virus genome and proliferative capacity of small cell lung cancer cell Lines
    Meeting Abstract

    Miles, L. A.; Hitchman, T.; Poirier, J.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted ADC effectively targets pulmonary neuroendocrine tumor-initiating cells to result in sustained tumor regressions
    Meeting Abstract

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. A.; Aujay, M.; Bheddah, S.; Black, K. A.; Desai, R.; Escarpe, P.; Hampl, J.; Park, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin-targeted CAR T-cell therapy for the treatment of heterogeneous antigen-expressing lung adenocarcinoma
    Meeting Abstract

    Morello, A.; Villena-Vargas, J.; Mayor, M.; Bograd, A. J.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-targeted radiation therapy helps overcome the solid tumor T-cell infiltration barrier and promotes mesothelin CAR T-cell therapy
    Meeting Abstract

    Mayor, M.; Villena-Vargas, J.; De Biasi, A.; Morello, A.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save